Evidence map›Paper›PMID 35814897›Full record

ArticleInternational journal of ophthalmology2022

iStent

Ataru Igarashi, Kyoko Ishida, Nobuyuki Shoji, Alice Chu, Heather Falvey, Ru Han, Maki Ueyama, Yoshie Onishi

Open access · goldAbstract read
In one paragraph

Article in International journal of ophthalmology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Clinical outcomes of combined cataract surgery with iStent injectGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. The PreserFlo MicroShunt in the Context of Minimally Invasive Glaucoma Surgery: A Narrative Review.International journal of environmental research and public health · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Ataru IgarashiUnit of Public Health and Preventive Medicine, Yokohama City University School of Medicine, Yokohama 236-0027, Japan.
Kyoko IshidaOhashi Medical Center, Toho University, Tokyo 153-8515, Japan.
Nobuyuki ShojiDepartment of Ophthalmology, Kitasato University Hospital, Kanagawa 252-0375, Japan.
Alice ChuMarket Access and Medical Marketing, Glaukos Singapore, Singapore 068896, Singapore.
Heather FalveyGlobal Health Economics, Glaukos Corp, California 92672, USA.
Ru HanHealth Economics and Outcomes Research, Creativ-Ceutical, Paris 75008, France.
Maki UeyamaHealth Economics and Outcomes Research, Creativ-Ceutical, Tokyo 108-6028, Japan.
Yoshie OnishiHealth Economics and Outcomes Research, Creativ-Ceutical, Tokyo 108-6028, Japan.
Creativ-Ceutical (France) · FRGlaukos (United States) · USKitasato University Hospital · JPYokohama City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo evaluate the cost-utility of iStent

methodsA Markov model was adapted to estimate the cost-utility of iStent

resultsIn the probabilistic base case analysis, iStent

conclusionThe iStent

Indexed as

cataract surgerycost-utilityglaucomahealth-economic modeliStent inject®

Identifiers

PMID35814897
PMCPMC9203480
OpenAlexW4281986022

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.